1-6 of 6
eculizumab
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Is there a role for immunosuppression in antiphospholipid syndrome?

Ecem Sevim, Rohan Willis, Doruk Erkan
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 426–432.
https://doi.org/10.1182/hematology.2019000073
Published: 2019
Journal Articles

Complement-driven anemia: more than just paroxysmal nocturnal hemoglobinuria

Samuel A. Merrill, Robert A. Brodsky
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 371–376.
https://doi.org/10.1182/asheducation-2018.1.371
Published: 2018
Journal Articles

Update on the diagnosis and management of paroxysmal nocturnal hemoglobinuria

Charles J. Parker
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 208–216.
https://doi.org/10.1182/asheducation-2016.1.208
Published: 2016
Journal Articles

Management of Paroxysmal Nocturnal Hemoglobinuria in the Era of Complement Inhibitory Therapy

Charles J. Parker
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 21–29.
https://doi.org/10.1182/asheducation-2011.1.21
Published: 2011
Journal Articles

The Role of Complement Inhibition in PNH

Peter Hillmen
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 116–123.
https://doi.org/10.1182/asheducation-2008.1.116
Published: 2008
Journal Articles

Which Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Should Be Treated with Eculizumab?

Richard L. Haspel, Peter Hillmen
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 35.
https://doi.org/10.1182/asheducation-2008.1.35
Published: 2008